A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity

Published:2017-06-29 Issue:21 Volume:123 Page:4147-4157
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Lee Anne W. M.¹^ORCID,Tung Stewart Y.²,Ng Wai Tong³,Lee Victor¹,Ngan Roger K. C.⁴,Choi Horace C. W.¹,Chan Lucy L. K.³,Siu Lillian L.⁵,Ng Alice W. Y.²,Leung To Wai⁶,Yiu Harry H. Y.⁴,O'Sullivan Brian⁵,Chappell Rick⁷

Affiliation:

1. Department of Clinical Oncology; University of Hong Kong and University of Hong Kong Shenzhen Hospital; Hong Kong China

2. Tuen Mun Hospital; Hong Kong China

3. Pamela Youde Nethersole Eastern Hospital; Hong Kong China

4. Queen Elizabeth Hospital; Hong Kong China

5. Ontario Cancer Institute; Princess Margaret Cancer Centre; Toronto Ontario Canada

6. Queen Mary Hospital; Hong Kong China

7. Department of Biostatistics; University of Wisconsin Medical School; Madison Wisconsin

Funder

Hong Kong Cancer Fund

Ho Hung Chiu Medical Foundation, Limited

Hong Kong Anti-Cancer Society

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference19 articles.

1. Chemotherapy versus radiochemotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099;Al-Sarraf;J Clin Oncol.,1998

2. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety;Wee;J Clin Oncol.,2005

3. 4th FY Khoo Memorial Lecture 2008: Nasopharyngeal Cancer Workgroup-the past, the present and the future;Wee;Ann Acad Med Singapore.,2008

4. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of China;Chen;Int J Radiat Oncol Biol Phys.,2008

5. Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China;Chen;Cancer.,2013

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction versus Adjuvant Chemotherapy Combined with Concurrent Chemoradiation: What Is Beneficial in Locally Advanced Nasopharyngeal Carcinoma—A 5-Year Comparative Study at a Tertiary Care Center in North India;South Asian Journal of Cancer;2024-06-10

2. Enhancing efficacy and reducing toxicity: Therapeutic optimization in locoregionally advanced nasopharyngeal carcinoma;Cell Reports Medicine;2024-06

3. TPF induction chemotherapy versus PF adjuvant chemotherapy plus concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: a multicenter, randomized controlled phase III trial;2024-04-26

4. Deletion of concurrent chemotherapy on the basis of sequential chemoradiotherapy for non‐metastatic stage T4 nasopharyngeal carcinoma in IMRT era;Cancer Medicine;2024-02

5. The efficacy of induction chemotherapy or adjuvant chemotherapy added to concurrent chemoradiotherapy in T3-4N0-1M0 nasopharyngeal carcinoma: a propensity score-matched analysis;Cancer Biology & Therapy;2023-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3